Tech Company Financing Transactions
Pathalys Pharma Funding Round
Pathalys Pharma, based in Raleigh, secured $150 million from Carlyle Global Partners, OrbiMed and Abingworth.
Transaction Overview
Company Name
Announced On
1/18/2023
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series A
Investors
Carlyle Global Partners (Lead Investor)
OrbiMed (Lead Investor)
Proceeds Purpose
Pathalys is very excited to collaborate with Launch Tx and to have the backing of such an esteemed group of healthcare investors. Through this collaboration and transaction, Pathalys expects to be fully funded through the completion of its planned phase 3 trials, and pre-commercialization efforts for upacicalcet
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4242 Six Forks Rd 820
Raleigh, NC 27609
USA
Raleigh, NC 27609
USA
Phone
Undisclosed
Website
Email Address
Overview
At Pathalys Pharma, Inc. we are committed to improving the lives of patients through the development of enhanced therapeutics that improve the management of chronic kidney disease (CKD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neal Fowler
Chief Medical Officer
Theodore Danoff
Chief Operating Officer
Patrick Treanor
Co-Founder
Ashwin Ram
Co-Founder
Jay Shepard
VP - Finance
Greg Klatt
Browse more venture capital transactions:
Prev: 1/18/2023: Tabby venture capital transaction
Next: 1/18/2023: Mad Street Den venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs